A Study of Elpipodect (MK-8189) in Participants With Schizophrenia (MK-8189-014)
Clinical trial NCT05406440 · COMPLETED
Trial details
- NCT number
- NCT05406440
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-12
- Primary completion
- 2023-02-24
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.